Produced using a patented dry-spinning technology – CollaFibR™ from AMSBIO is a highly consistent collagen fibre matrix that closely mimics the biomechanical and biochemical properties of natural collagen scaffolds, offering a highly accurate representation of in-vivo conditions. These innovative collagen fibres are seamlessly produced on a commercial scale using an automated state-of-the-art Good Manufacturing Process, […]

GLENDALE HEIGHTS, Ill. — Ampersand Capital Partners (“Ampersand”), a private equity firm specializing in growth equity investments in the life sciences and healthcare sectors, announced today the acquisition of Biologos LLC (“Biologos”), a full-service manufacturer of custom and standard cell culture media, reagents, buffers, enzymes, and sera. The partnership with Ampersand will include investments to expand Biologos’ […]

Experienced executive with extensive background as CFO for global corporations across dynamic sectors Cytek reaffirms 2024 outlook FREMONT, Calif. — Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that William (Bill) McCombe has been appointed chief financial officer of the company effective immediately. McCombe brings experience as a public company CFO at both large scale, and […]

WALTHAM, Mass. — Repligen Corporation (NASDAQ:RGEN) today announced the appointment to its Board of Directors of life sciences industry executive Maggie A. Pax. This appointment expands the size of Repligen’s board from eight to nine members. Ms. Pax brings to Repligen over 25 years of experience leading the development and execution of growth strategies for […]

Bringing End-to-End Spatial Biology Solutions to Life Sciences Researchers for Advanced Spatial Proteomics Analysis WALTHAM, Mass. —  BostonGene, a leading provider of AI-driven molecular and immune profiling solutions, announced today that it has been named as a qualified contract research organization (CRO) of Akoya Biosciences (Nasdaq: AKYA; “Akoya”). By combining Akoya’s single-cell imaging solutions with BostonGene’s unparalleled […]

As of the 1st of April 2024, MyBio Ltd. will be the main point of contact for sales and supply of QIAGEN’s world leading “Sample to Insight” solutions for life science customers throughout the island of Ireland.  MyBio‘s Founder & CEO, Linda Nolan is delighted to announce this new exclusive partnership with QIAGEN to distribute their Life Science research product portfolio throughout […]

SAN JOSE, Calif. — Nodexus Inc., an emerging leader in automated benchtop single-cell characterization and microfluidic isolation technologies, today announced that William (Bill) Rhodes has been named Executive Chairman of the company’s Board of Directors. Rhodes has served on the Nodexus Board as an Independent Director since 2021 and was previously an Advisor to the […]

Executive brings more than 25 years of experience in life sciences SAN JOSE, Calif. – Molecular Devices, LLC., a leading high-performance life science solutions provider and an operating company in the life sciences segment of Danaher Corporation (NYSE:DHR), today announced Mary Duseau’s appointment as its new president, succeeding interim president, Greg Milosevich. “Mary brings more than 25 […]

New ResolveDNA® and ResolveOME™ single-cell kits generate sequencing-ready libraries in under eight hours DURHAM, N.C. – BioSkryb Genomics, a company ushering in the next generation of single-cell technology, today announced the commercial launch of its new ResolveDNA Whole Genome and ResolveOME Whole Genome and Transcriptome Single-Cell Core Kits, which are now available to U.S. and international […]